Why the study?
Cardiovascular prevention has become a dominant trend, but guidance across different life stages was needed to describe prevention in young, middle, elderly, and senile age.
This review emphasizes the importance of a lifelong, integrated biopsychosocial approach to cardiovascular disease prevention starting as early as possible.
Answers are grounded in this paper and cite their sources.
Supports early lifelong prevention; leaves open optimal timing and intensity from prospective trials.
Intensive investigation of cardiovascular disease (CVD) risk factors (RFs), both traditional (smoking, dyslipidemia, diabetes, etc.) and non-traditional, which are a component of the so-called exposome, as well as their non-drug and drug correction provide wide prospects for effective cardiovascular prevention. Prevention becomes the dominant trend in cardiology and in medicine in general. The aim of the article was to describe cardiovascular prevention in young, middle, elderly and senile age. Due to the multifaceted nature of cardiovascular RFs, an integrated biopsychosocial approach, individual and population-based prevention, cumulative risk assessment of all CVDs, intersectoral collaboration and the involvement of decision-makers, are key to the success and effectiveness of prevention measures. It is important to note that, on the one hand, preventive measures should be started as early as possible due to cumulative effect of RFs, on the other hand, most of the preventive interventions for CVD are extremely relevant at all life stages.
No takes yet. Share an insight, caveat, or question.
Kopylova et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: